Patheon: latest news - GoINPHARMA
Tuesday, 23 April 2019 - 5:38


Confirmed: Patheon acquired by Thermo Fisher for $7.2bn

Thermo Fisher Scientific announced as trading opened (Wall Street) it has acquired Netherlands-based Patheon NV for $7.2bn. Thermo Fisher valued Patheon at $35 per share, which represents a premium 35% over Friday’s closing price – $26. Thermo Fisher’s shares rose…

Patheon’s shares up 34% on rumors of acquisition by Thermo Fisher

Thermo Fisher, the world’s biggest company in the diagnostic and testing equipment business, is reportedly about to acquire Netherlands-based Patheon NV, a pharmaceutical intermediate producer which was listed only one year ago, but already has a market capitalization of as…